Search details
1.
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.
Clin Cancer Res
; 29(11): 2123-2130, 2023 06 01.
Article
in English
| MEDLINE | ID: mdl-36913537
2.
Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations.
Nat Commun
; 13(1): 6791, 2022 11 10.
Article
in English
| MEDLINE | ID: mdl-36357385
3.
Kinetics of receptor tyrosine kinase activation define ERK signaling dynamics.
Sci Signal
; 13(645)2020 08 18.
Article
in English
| MEDLINE | ID: mdl-32817373
4.
Drug Sensitivity and Allele Specificity of First-Line Osimertinib Resistance EGFR Mutations.
Cancer Res
; 80(10): 2017-2030, 2020 05 15.
Article
in English
| MEDLINE | ID: mdl-32193290
Results
1 -
4
de 4
1
Next >
>>